How long do I need to take dasatinib?
Dasatinib (Dasatinib) is a commonly used targeted therapy drug, mainly used to treat patients with chronic myeloid leukemia (CML) and some acute lymphoblastic leukemia (ALL). The time of use of Dasatinib (Startaxed) usually depends on the patient's condition, treatment response and doctor's advice. Generally speaking, patients need to take Dasatinib (Startaxed) for a long time until the treatment goal is achieved or treatment failure or intolerance occurs.
1.Chronic myelogenous leukemia (CML):

For patients with CML, dasatinib (Startase) is generally considered a long-term treatment option with the goal of achieving and maintaining sustained molecular and clinical responses. Once a patient achieves a sustained complete or partial molecular response, dasatinib is often continued to maintain that response, and the treatment period may last several years or longer.
For some CML patients, dasatinib (Startase) may be a lifelong treatment until treatment failure or intolerable adverse effects occur. In this case, the doctor may consider adjusting the treatment plan or switching to another treatment.
2.Acute lymphoblastic leukemia (ALL):
For some patients with Ph+ ALL, dasatinib (Startase) may be used as first-line treatment or as a treatment option for relapsed / refractory disease. In this case, dasatinib (Startase) is often used in combination with chemotherapy drugs to make the treatment more effective. Treatment cycles and duration may vary depending on the patient's specific condition, but long-term administration of dasatinib (Startase) is generally required to maintain treatment response.
For Ph+ ALLpatients,the duration of treatment with dasatinib may also be affected by other treatment options, such as stem cell transplantation. In some cases,Dasatinib (Startase) may be used as a conditioning treatment to prepare patients for stem cell transplantation.
In general, the duration of use of dasatinib varies depending on the patient's condition and treatment plan, but it usually requires long-term use to maintain the therapeutic effect. Patients should closely follow their doctor's recommendations and undergo regular follow-up and testing to evaluate treatment response and adjust treatment options. Maintain close communication with the medical team throughout the entire treatment process to ensure optimal treatment results.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)